Systemic-pulmonary collateral supply associated with clinical severity of chronic thromboembolic pulmonary hypertension: a study using intra-aortic computed tomography angiography.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 28 10 2021
accepted: 23 03 2022
revised: 11 03 2022
pubmed: 15 4 2022
medline: 19 11 2022
entrez: 14 4 2022
Statut: ppublish

Résumé

To assess whether systemic-pulmonary collaterals are associated with clinical severity and extent of pulmonary perfusion defects in chronic thromboembolic pulmonary hypertension (CTEPH). This prospective study was approved by a local ethics committee. Twenty-four patients diagnosed with inoperable CTEPH were enrolled between July 2014 and February 2017. Systemic-pulmonary collaterals were detected using pulmonary vascular enhancement on intra-aortic computed tomography (CT) angiography. The pulmonary enhancement parameters were calculated, including (1) Hounsfield unit differences (HUdiff) between pulmonary trunks and pulmonary arteries (PAs) or veins (PVs), namely HUdiff-PA and HUdiff-PV, on the segmental base; (2) the mean HUdiff-PA, mean HUdiff-PV, numbers of significantly enhanced PAs and PVs, on the patient base. Pulmonary perfusion defects were recorded and scored using the lung perfused blood volume (PBV) based on intravenous dual-energy CT (DECT) angiography. Pearson's or Spearman's correlation coefficients were used to evaluate correlations between the following: (1) segment-based intra-aortic CT and intravenous DECT parameters (2) patient-based intra-aortic CT parameters and clinical severity parameters or lung PBV scores. Statistical significance was set at p < 0.05. Segmental HUdiff-PV was correlated with the segmental perfusion defect score (r = 0.45, p < 0.01). The mean HUdiff-PV was correlated with the mean pulmonary arterial pressure (PAP) (r = 0.52, p < 0.01), cardiac output (rho = - 0.41, p = 0.05), and lung PBV score (rho = 0.43, p = 0.04). And the number of significantly enhanced PVs was correlated with the mean PAP (r = 0.54, p < 0.01), pulmonary vascular resistance (r = 0.54, p < 0.01), and lung PBV score (rho = 0.50, p = 0.01). PV enhancement measured by intra-aortic CT angiography reflects clinical severity and pulmonary perfusion defects in CTEPH. • Intra-aortic CT angiography demonstrated heterogeneous enhancement within the pulmonary vasculature, showing collaterals from the systemic arteries to the pulmonary circulation in CTEPH. • The degree of systemic-pulmonary collateral development was significantly correlated with the clinical severity of CTEPH and may be used to evaluate disease progression. • The distribution of systemic-pulmonary collaterals is positively correlated with perfusion defects in the lung segments in CTEPH.

Identifiants

pubmed: 35420297
doi: 10.1007/s00330-022-08768-6
pii: 10.1007/s00330-022-08768-6
pmc: PMC9668953
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7668-7679

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 16K10265

Informations de copyright

© 2022. The Author(s).

Références

Kim NH, Delcroix M, Jais X et al (2019) Chronic thromboembolic pulmonary hypertension. Eur Respir J 53:30545969. https://doi.org/10.1183/13993003.01915-2018
doi: 10.1183/13993003.01915-2018
Galiè N, McLaughlin VV, Rubin LJ, Simonneau G (2019). Eur Respir J, vol 53 An overview of the 6th World Symposium on Pulmonary Hypertension. https://doi.org/10.1183/13993003.02148-2018 , 1802148
Stricker H (2016) Chronic thromboembolic pulmonary hypertension - A diagnostic and therapeutic update. Vasa 45:195–199. https://doi.org/10.1024/0301-1526/a000525
doi: 10.1024/0301-1526/a000525
Lang IM, Dorfmüller P, Vonk Noordegraaf AV (2016) The pathobiology of chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc 13(Supplement 3):S215–S221. https://doi.org/10.1513/AnnalsATS.201509-620AS
doi: 10.1513/AnnalsATS.201509-620AS
Wilkens H, Konstantinides S, Lang IM et al (2018) Chronic thromboembolic pulmonary hypertension (CTEPH): updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol 272S:69–78. https://doi.org/10.1016/j.ijcard.2018.08.079
doi: 10.1016/j.ijcard.2018.08.079
Dorfmüller P, Günther S, Ghigna MR et al (2014) Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature. Eur Respir J 44:1275–1288. https://doi.org/10.1183/09031936.00169113
doi: 10.1183/09031936.00169113
Endrys J, Hayat N, Cherian G (1997) Comparison of bronchopulmonary collaterals and collateral blood flow in patients with chronic thromboembolic and primary pulmonary hypertension. Heart 78:171–176. https://doi.org/10.1136/hrt.78.2.171
doi: 10.1136/hrt.78.2.171
Charan NB, Carvalho P (1997) Angiogenesis in bronchial circulatory system after unilateral pulmonary artery obstruction. J Appl Physiol (1985) 82:284–291. https://doi.org/10.1152/jappl.1997.82.1.284
doi: 10.1152/jappl.1997.82.1.284
Delcroix M, Vonk Noordegraaf A, Fadel E et al (2013) Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension. Eur Respir J 41:224–232. https://doi.org/10.1183/09031936.00047712
doi: 10.1183/09031936.00047712
Shimizu H, Tanabe N, Terada J et al (2008) Dilatation of bronchial arteries correlates with extent of central disease in patients with chronic thromboembolic pulmonary hypertension. Circ J 72:1136–1141. https://doi.org/10.1253/circj.72.1136
doi: 10.1253/circj.72.1136
Mitzner W, Wagner EM (2004) Vascular remodeling in the circulations of the lung. J Appl Physiol (1985) 97:1999–2004. https://doi.org/10.1152/japplphysiol.00473.2004
doi: 10.1152/japplphysiol.00473.2004
Capone C, Valentini A, Spinillo SL et al (2021) Radiological differences between chronic thromboembolic pulmonary disease (CTEPD) and chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol. https://doi.org/10.1007/s00330-020-07556-4
Ley S, Kreitner KF, Morgenstern I et al (2002) Bronchopulmonary shunts in patients with chronic thromboembolic pulmonary hypertension: Evaluation with helical CT and MR imaging. AJR Am J Roentgenol 179:1209–1215. https://doi.org/10.2214/ajr.179.5.1791209
doi: 10.2214/ajr.179.5.1791209
Simonneau G, Torbicki A, Dorfmüller P, Kim N (2017) The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 26:28356405. https://doi.org/10.1183/16000617.0112-2016
doi: 10.1183/16000617.0112-2016
Gerges C, Gerges M, Friewald R et al (2020) Microvascular disease in chronic thromboembolic pulmonary hypertension: hemodynamic Phenotyping and Histomorphometric Assessment. Circulation 141:376–386. https://doi.org/10.1161/CIRCULATIONAHA.119.041515
doi: 10.1161/CIRCULATIONAHA.119.041515
Gan HL, Zhang JQ, Sun JC et al (2014) Preoperative transcatheter occlusion of bronchopulmonary collateral artery reduces reperfusion pulmonary edema and improves early hemodynamic function after pulmonary thromboendarterectomy. J Thorac Cardiovasc Surg 148:3014–3019. https://doi.org/10.1016/j.jtcvs.2014.05.024
doi: 10.1016/j.jtcvs.2014.05.024
Yang S, Wang J, Kuang T et al (2019) Efficacy and safety of bronchial artery embolization on hemoptysis in chronic thromboembolic pulmonary hypertension: a pilot prospective cohort study. Crit Care Med 47:e182–e189. https://doi.org/10.1097/CCM.0000000000003578
doi: 10.1097/CCM.0000000000003578
Nagao M, Yamasaki Y, Abe K et al (2017) Energy efficiency and pulmonary artery flow after balloon pulmonary angioplasty for inoperable, chronic thromboembolic pulmonary hypertension: Analysis by phase-contrast MRI. Eur J Radiol 87:99–104. https://doi.org/10.1016/j.ejrad.2016.12.015
doi: 10.1016/j.ejrad.2016.12.015
Masy M, Giordano J, Petyt G et al (2018) Dual-energy CT (DECT) lung perfusion in pulmonary hypertension: concordance rate with V/Q scintigraphy in diagnosing chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol 28:5100–5110. https://doi.org/10.1007/s00330-018-5467-2
doi: 10.1007/s00330-018-5467-2
Takagi H, Ota H, Sugimura K et al (2016) Dual-energy CT to estimate clinical severity of chronic thromboembolic pulmonary hypertension: comparison with invasive right heart catheterization. Eur J Radiol 85:1574–1580. https://doi.org/10.1016/j.ejrad.2016.06.010
doi: 10.1016/j.ejrad.2016.06.010
Nakazawa T, Watanabe Y, Hori Y et al (2011) Lung perfused blood volume images with dual-energy computed tomography for chronic thromboembolic pulmonary hypertension: correlation to scintigraphy with single-photon emission computed tomography. J Comput Assist Tomogr 35:590–595. https://doi.org/10.1097/RCT.0b013e318224e227
doi: 10.1097/RCT.0b013e318224e227
Dournes G, Verdier D, Montaudon M et al (2014) Dual-energy CT perfusion and angiography in chronic thromboembolic pulmonary hypertension: diagnostic accuracy and concordance with radionuclide scintigraphy. Eur Radiol 24:42–51. https://doi.org/10.1007/s00330-013-2975-y
doi: 10.1007/s00330-013-2975-y
Giordano J, Khung S, Duhamel A et al (2017) Lung perfusion characteristics in pulmonary arterial hypertension (PAH) and peripheral forms of chronic thromboembolic pulmonary hypertension (pCTEPH): dual-energy CT experience in 31 patients. Eur Radiol 27:1631–1639. https://doi.org/10.1007/s00330-016-4500-6
doi: 10.1007/s00330-016-4500-6
Koike H, Sueyoshi E, Sakamoto I et al (2018) Comparative clinical and predictive value of lung perfusion blood volume CT, lung perfusion SPECT and catheter pulmonary angiography images in patients with chronic thromboembolic pulmonary hypertension before and after balloon pulmonary angioplasty. Eur Radiol 28:5091–5099. https://doi.org/10.1007/s00330-018-5501-4
doi: 10.1007/s00330-018-5501-4
Le Faivre J, Duhamel A, Khung S et al (2016) Impact of CT perfusion imaging on the assessment of peripheral chronic pulmonary thromboembolism: clinical experience in 62 patients. Eur Radiol 26:4011–4020. https://doi.org/10.1007/s00330-016-4262-1
doi: 10.1007/s00330-016-4262-1
Foti G, Silva R, Faccioli N et al (2021) Identification of pulmonary embolism: diagnostic accuracy of venous-phase dual-energy CT in comparison to pulmonary arteries CT angiography. Eur Radiol 31:1923–1931. https://doi.org/10.1007/s00330-020-07286-7
doi: 10.1007/s00330-020-07286-7
Joshi SB, Mendoza DD, Steinberg DH et al (2009) Ultra-low-dose intra-arterial contrast injection for iliofemoral computed tomographic angiography. JACC Cardiovasc Imaging 2:1404–1411. https://doi.org/10.1016/j.jcmg.2009.08.010
doi: 10.1016/j.jcmg.2009.08.010
Gandhi D, Pandey A, Ansari SA et al (2009) Multi-detector row CT angiography with direct intra-arterial contrast injection for the evaluation of neurovascular disease: Technique, applications, and initial experience. AJNR Am J Neuroradiol 30:1054–1058. https://doi.org/10.3174/ajnr.A1438
doi: 10.3174/ajnr.A1438
Yi Y, Zhao XM, Wu RZ et al (2019) Low dose and low contrast medium coronary CT angiography using dual-layer spectral detector CT. Int Heart J 60:608–617. https://doi.org/10.1536/ihj.18-340
doi: 10.1536/ihj.18-340
Zhou G, Dada LA, Wu M et al (2009) Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1. Am J Physiol Lung Cell Mol Physiol 297:L1120–L1130. https://doi.org/10.1152/ajplung.00007.2009
doi: 10.1152/ajplung.00007.2009
Orell SR, Hultgren S (1966) Anastomoses between bronchial and pulmonary arteries in pulmonary arteries in pulmonary thromboembolic disease. Acta Pathol Microbiol Scand 67:322–338. https://doi.org/10.1111/apm.1966.67.3.322
doi: 10.1111/apm.1966.67.3.322

Auteurs

Wenyu Sun (W)

Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

Hideki Ota (H)

Department of Advanced MRI Collaboration Research, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan. h-ota@rad.med.tohoku.ac.jp.
Department of Diagnostic Radiology, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. h-ota@rad.med.tohoku.ac.jp.

Haruka Sato (H)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

Saori Yamamoto (S)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

Shunsuke Tatebe (S)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

Tatsuo Aoki (T)

Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

Koichiro Sugimura (K)

Department of Cardiology, International University of Health and Welfare, Narita Hospital, 852, Hatakeda, Narita Chiba, 286-0124, Japan.

Junya Tominaga (J)

Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

Hiroaki Shimokawa (H)

Graduate School, International University of Health and Welfare, School of Medicine, 4-3 Kozunomori, Narita Chiba, 286-8686, Japan.

Takuya Ueda (T)

Department of Diagnostic Radiology, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Department of Clinical Imaging, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

Kei Takase (K)

Department of Diagnostic Radiology, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
Department of Advanced MRI Collaboration Research, Tohoku University Graduate School of Medicine, 2-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
Department of Diagnostic Radiology, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH